BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 73 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $63,286 | -23.0% | 22,051 | +35.5% | 0.00% | – |
Q2 2023 | $82,158 | +55.4% | 16,269 | -41.8% | 0.00% | – |
Q1 2023 | $52,871 | -5.9% | 27,974 | -10.3% | 0.00% | – |
Q4 2022 | $56,164 | -85.5% | 31,202 | -86.4% | 0.00% | – |
Q3 2022 | $387,000 | -70.7% | 229,189 | -57.3% | 0.00% | – |
Q2 2022 | $1,319,000 | -3.4% | 536,220 | +8.7% | 0.00% | – |
Q1 2022 | $1,366,000 | -66.9% | 493,362 | -36.3% | 0.00% | -100.0% |
Q4 2021 | $4,127,000 | -35.9% | 773,936 | +1.7% | 0.00% | 0.0% |
Q3 2021 | $6,439,000 | -12.1% | 761,091 | +26.6% | 0.00% | 0.0% |
Q2 2021 | $7,327,000 | +2255.9% | 601,020 | +4599.9% | 0.00% | – |
Q1 2021 | $311,000 | -91.3% | 12,788 | -88.5% | 0.00% | -100.0% |
Q4 2020 | $3,578,000 | +1292.2% | 111,661 | +1212.0% | 0.00% | – |
Q3 2020 | $257,000 | +59.6% | 8,511 | +123.0% | 0.00% | – |
Q2 2020 | $161,000 | +360.0% | 3,816 | +170.6% | 0.00% | – |
Q1 2020 | $35,000 | – | 1,410 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 3,449,845 | $104,289,000 | 4.42% |
Boxer Capital, LLC | 2,014,858 | $60,909,000 | 2.10% |
RA Capital Management | 2,589,904 | $78,293,000 | 1.43% |
Artal Group S.A. | 1,521,517 | $45,995,000 | 1.12% |
Ikarian Capital, LLC | 358,941 | $10,851,000 | 0.78% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $24,260,000 | 0.59% |
Bellevue Group AG | 1,403,000 | $42,413,000 | 0.59% |
Logos Global Management LP | 123,465 | $3,732,000 | 0.48% |
Casdin Capital, LLC | 289,395 | $8,748,000 | 0.39% |
HighVista Strategies LLC | 16,391 | $496,000 | 0.36% |